P

Inventor

CHASIN MARK

US81 patents
⚠️ This page may combine multiple inventors who share the name “CHASIN MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

EURO CELTIQUE SA

35 patents
US6706281B2Mar 16, 2004

Melt-extrusion multiparticulates

EURO CELTIQUE SA191 citations99
US6387404B2May 14, 2002

Immediate release tablet cores of insoluble drugs having sustained-release coating

EURO CELTIQUE SA220 citations99
US6335033B2Jan 1, 2002

Melt-extrusion multiparticulates

EURO CELTIQUE SA280 citations99
US6306438B1Oct 23, 2001

Stabilized sustained release tramadol formulations

EURO CELTIQUE SA207 citations99
US6210714B1Apr 3, 2001

Immediate release tablet cores of acetaminophen having sustained-release coating

EURO CELTIQUE SA239 citations99
US6024982AFeb 15, 2000

Immediate release tablet cores of insoluble drugs having sustained-release coating

EURO CELTIQUE SA323 citations99
US5965161AOct 12, 1999

Extruded multi-particulates

EURO CELTIQUE SA471 citations99
US5958452ASep 28, 1999

Extruded orally administrable opioid formulations

EURO CELTIQUE SA519 citations99
US5747060AMay 5, 1998

Prolonged local anesthesia with colchicine

EURO CELTIQUE SA346 citations99
US5716611AFeb 10, 1998

Emollient antimicrobial formulations containing povidone iodine

EURO CELTIQUE SA155 citations99
US5681585AOct 28, 1997

Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer

EURO CELTIQUE SA291 citations99
US5639476AJun 17, 1997

Controlled release formulations coated with aqueous dispersions of acrylic polymers

EURO CELTIQUE SA2,177 citations99
US5580578ADec 3, 1996

Controlled release formulations coated with aqueous dispersions of acrylic polymers

EURO CELTIQUE SA507 citations99
US5500227AMar 19, 1996

Immediate release tablet cores of insoluble drugs having sustained-release coating

EURO CELTIQUE SA473 citations99
US5472712ADec 5, 1995

Controlled-release formulations coated with aqueous dispersions of ethylcellulose

EURO CELTIQUE SA603 citations99
US5286493AFeb 15, 1994

Stabilized controlled release formulations having acrylic polymer coating

EURO CELTIQUE SA630 citations99
US5273760ADec 28, 1993

Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer

EURO CELTIQUE SA560 citations99
US6921541B2Jul 26, 2005

Formulations and methods for providing prolonged local anesthesia

EURO CELTIQUE SA183 citations98
US6743442B2Jun 1, 2004

Melt-extruded orally administrable opioid formulations

EURO CELTIQUE SA181 citations98
US6524607B1Feb 25, 2003

Formulations and methods for providing prolonged local anesthesia

EURO CELTIQUE SA262 citations98
US6261599B1Jul 17, 2001

Melt-extruded orally administrable opioid formulations

EURO CELTIQUE SA394 citations98
US5942241AAug 24, 1999

Formulations and methods for providing prolonged local anesthesia

EURO CELTIQUE SA346 citations98
US5549912AAug 27, 1996

Controlled release oxycodone compositions

EURO CELTIQUE SA522 citations98
US5356467AOct 18, 1994

Controlled release coatings derived from aqueous dispersions of zein

EURO CELTIQUE SA497 citations98
US5324351AJun 28, 1994

Aqueous dispersions of zein and preparation thereof

EURO CELTIQUE SA350 citations98
US5266331ANov 30, 1993

Controlled release oxycodone compositions

EURO CELTIQUE SA542 citations98
US6699908B2Mar 2, 2004

Methods for providing safe local anesthesia

EURO CELTIQUE SA91 citations97
US6534081B2Mar 18, 2003

Prolonged anesthesia in joints and body spaces

EURO CELTIQUE SA221 citations97
US6248345B1Jun 19, 2001

Prolonged anesthesia in joints and body spaces

EURO CELTIQUE SA284 citations97
US6521259B1Feb 18, 2003

Formulations and methods for providing prolonged local anesthesia

EURO CELTIQUE SA69 citations96
US6514516B1Feb 4, 2003

Formulations and methods for providing prolonged local anesthesia

EURO CELTIQUE SA70 citations96
US6451335B1Sep 17, 2002

Formulations and methods for providing prolonged local anesthesia

EURO CELTIQUE SA135 citations95
US6228859B1May 8, 2001

Purine derivatives having phosphodiesterase IV inhibition activity

EURO CELTIQUE SA32 citations95
US5656295AAug 12, 1997

Controlled release oxycodone compositions

EURO CELTIQUE SA491 citations95
US5922751AJul 13, 1999

Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same

EURO CELTIQUE SA40 citations94

PURDUE PHARMA LP

13 patents
US6572885B2Jun 3, 2003

Orally administrable opioid formulations having extended duration of effect

PURDUE PHARMA LP264 citations99
US6316031B1Nov 13, 2001

Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer

PURDUE PHARMA LP96 citations99
US6294195B1Sep 25, 2001

Orally administrable opioid formulations having extended duration of effect

PURDUE PHARMA LP327 citations99
US6143353ANov 7, 2000

Controlled release formulations coated with aqueous dispersions of acrylic polymers

PURDUE PHARMA LP141 citations99
US6129933AOct 10, 2000

Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer

PURDUE PHARMA LP171 citations99
US6103261AAug 15, 2000

Opioid formulations having extended controlled release

PURDUE PHARMA LP346 citations99
US5968551AOct 19, 1999

Orally administrable opioid formulations having extended duration of effect

PURDUE PHARMA LP561 citations99
US5958459ASep 28, 1999

Opioid formulations having extended controlled released

PURDUE PHARMA LP388 citations99
US6905709B2Jun 14, 2005

Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer

PURDUE PHARMA LP104 citations98
US7316821B2Jan 8, 2008

Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer

PURDUE PHARMA LP50 citations96
US7070806B2Jul 4, 2006

Controlled release formulations coated with aqueous dispersions of acrylic polymers

PURDUE PHARMA LP54 citations96
US7510727B2Mar 31, 2009

Melt-extrusion multiparticulates

PURDUE PHARMA LP24 citations93
US7270831B2Sep 18, 2007

Orally administrable opioid formulations having extended duration of effect

PURDUE PHARMA LP21 citations93

EURO CELTIGUE S A

1 patent
US5508042AApr 16, 1996

Controlled release oxycodone compositions

EURO CELTIGUE S A676 citations96

MASSACHUSETTS INST TECHNOLOGY

1 patent
US5122367AJun 16, 1992

Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone

MASSACHUSETTS INST TECHNOLOGY105 citations94

Showing the top 50 of 81 patents by PatentIndex Score.